Over 15M people take GLP-1 drugs in America and 54% agree on same issue
More than 15 million people in the United States now use GLP-1 medications. These drugs are altering consumer eating habits and reshaping the food industry, particularly for snack makers. While they have reached widespread popularity, researchers are still investigating potential side effects involving vision, nails, and hair. The market for these medications is expanding rapidly, generating 79 billion dollars in sales in 2025 with projections reaching 190 billion dollars by 2035. Some insurance payers have responded to the surge by introducing coverage limits to control costs.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ Over 15 million people in America take GLP-1 drugs.
- ✓ GLP-1 drugs generated 79 billion dollars in sales in 2025.
- ✓ The GLP-1 market could reach 190 billion dollars by 2035.
- ✓ GLP-1 medications are changing how people eat and affecting consumer behavior.
What changed
Recent data confirms over 15 million American users and 79 billion dollars in 2025 sales.
Live updates
-
Over 15 Million Americans Use GLP-1 Drugs as Market Scales
More than 15 million people in the United States now use GLP-1 medications. These drugs are altering consumer eating habits and reshaping the food industry, particularly for snack makers. While they have reached widespread popularity, researchers are still investigating potential side effects involving vision, nails, and hair. The market for these medications is expanding rapidly, generating 79 billion dollars in sales in 2025 with projections reaching 190 billion dollars by 2035. Some insurance payers have responded to the surge by introducing coverage limits to control costs.
Why it matters
GLP-1 receptor agonists were originally designed for diabetes but have become a cultural phenomenon for weight loss. Their ability to change biological age and consumer behavior makes them a significant economic force. The rapid adoption has created a new intersection between pharmaceutical sales and consumer retail habits.
What is confirmed
- Over 15 million people in America take GLP-1 drugs.
- GLP-1 drugs generated 79 billion dollars in sales in 2025.
- The GLP-1 market could reach 190 billion dollars by 2035.
- GLP-1 medications are changing how people eat and affecting consumer behavior.
Still unconfirmed
- More than 1 in 10 US adults now take weight-loss drugs.
What to watch next
- Changes in insurance coverage policies for weight-loss prescriptions.
confidence 85%Sources used for this update (12)
- Fierce Pharma — How drugmakers are tapping into the GLP-1 frenzy's unprecedented 'consumer overlay'
- www.technologyreview.com — We’re still figuring out the side effects of GLP-1 weight-loss drugs
- www.fool.com — As GLP-1 Drugs Change How People Eat, Drugmakers Collect and Snack Makers Feel the Squeeze
- The Mirror US — Over 15M people take GLP-1 drugs in America and 54% agree on same issue
- BBC Science Focus Magazine — 5 surprising lessons about GLP-1s, from the scientists who study them
- Olhar Digital — fda approved peptides for weight loss
- www.trifactadata.com — GLP-1 and Protein Foods: What the Data Shows | Trifacta Data
- welltica.com — More than 1 in 10 US adults now take weight-loss drugs
- hcai.ca.gov — Data Brief: GLP-1 Prescriptions for Weight Loss over Time ...
- explodingtopics.com — GLP-1 Market Size and Sales Statistics (October 2026)
- www.medscape.com — Patients Taking GLP-1s Face a Double Dose of Stigma - Medscape
- www.milbank.org — What a Maturing GLP-1 Market Reveals About Modern Drug ...
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community